- testing |
No Record Found
Sector
PharmaceuticalsOpen
₹846Prev. Close
₹850.2Turnover(Lac.)
₹278.72Day's High
₹857.8Day's Low
₹843.0552 Week's High
₹1,997.452 Week's Low
₹603.8Book Value
₹251.57Face Value
₹10Mkt Cap (₹ Cr.)
4,311.12P/E
59.69EPS
14.23Divi. Yield
029 May 2025
12:00 AM
EGM
5 Nov 2025
12:00 AM
Board Meeting
Agenda : Audited Result
12 Aug 2025
12:00 AM
AGM
Announcement Date: 12 Aug, 2025
No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 119.28 | 119.28 | 109.38 | 109.38 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 1,204.77 | 1,099.04 | 622.59 | 568.58 |
Net Worth | 1,324.05 | 1,218.32 | 731.97 | 677.96 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 556.97 | 450.69 | 505.44 | 644.16 |
yoy growth (%) | 23.58 | -10.83 | -21.53 | -14.71 |
Raw materials | -314.07 | -229.27 | -240.23 | -330.86 |
As % of sales | 56.38 | 50.87 | 47.52 | 51.36 |
Employee costs | -60.2 | -64.39 | -81.48 | -82.39 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | -52.77 | -95.87 | -149.83 | -401.47 |
Depreciation | -87.02 | -108.89 | -125.9 | -133.29 |
Tax paid | 0 | 0 | 0 | 46.19 |
Working capital | -202.58 | -42.4 | 475.45 | -144.74 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 23.58 | -10.83 | -21.53 | -14.71 |
Op profit growth | -1.1 | -230.8 | -425.39 | -703.41 |
EBIT growth | -53.38 | -69.42 | 45.93 | -12.7 |
Net profit growth | -95.89 | -21.81 | -57.82 | -27.27 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 921.93 | 819.37 | 665.9 | 559.56 | 450.06 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 921.93 | 819.37 | 665.9 | 559.56 | 450.06 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 27.47 | 30.86 | 58.64 | 67.47 | 15.23 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,799.5 | 92.3 | 4,31,412.42 | 564.22 | 0.89 | 4,511.27 | 99.24 |
Divis Laboratories Ltd DIVISLAB | 6,417.5 | 67.76 | 1,70,343.22 | 696 | 0.47 | 2,660 | 578.26 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,728 | 59.13 | 1,26,185.41 | 597 | 0.16 | 2,707 | 249.83 |
Cipla Ltd CIPLA | 1,516.6 | 23.57 | 1,22,510.62 | 1,210.53 | 1.05 | 4,495.16 | 411.56 |
Dr Reddys Laboratories Ltd DRREDDY | 1,275.2 | 19.73 | 1,06,522.7 | 387.3 | 0.63 | 4,602.9 | 377.56 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman(Non Exe)&Dir(Non-Ind)
R G Agarwal
Executive Director & MD
Manish Dhanuka
E D & Wholetime Director
Mridul Dhanuka
Non-Exec & Non-Independent Dir
Arjun Dhanuka
Independent Non Exe. Director
Dharam Vir
Independent Non Exe. Director
Manoj Goyal
Independent Non Exe. Director
Tanu Singla
Independent Non Exe. Director
Shubha Singh
Company Sec. & Compli. Officer
Kapil Dayya
Orchid Towers Nungambakkam,
313 Valluvar Kottam High Road,
Tamil Nadu - 600034
Tel: 91-44-28211000/28230000
Website: http://www.orchidpharma.com
Email: corporate@orchidpharma.com
Tel: -
Website: -
Email: -
Summary
Orchid Pharma Limited, is a vertically integrated pharmaceutical company with established research, manufacturing and marketing capabilities across multi-therapeutic domains. Orchids world class manuf...
Read More
Reports by Orchid Pharma Ltd
What is the Orchid Pharma Ltd share price today?
What is the Market Cap of Orchid Pharma Ltd?
What is the PE and PB ratio of Orchid Pharma Ltd?
What is the 52 Week High and Low of Orchid Pharma Ltd?
What is the CAGR of Orchid Pharma Ltd?
What is the shareholding pattern of Orchid Pharma Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.